123 related articles for article (PubMed ID: 26899324)
1. [Research advances of K-ras mutation in the prognosis and targeted therapy of gastric cancer].
Huang Y; Wei J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):81-5. PubMed ID: 26899324
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutation influences macroscopic features of gastric carcinoma.
Yashiro M; Nishioka N; Hirakawa K
J Surg Res; 2005 Mar; 124(1):74-8. PubMed ID: 15734482
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.
Kim IJ; Park JH; Kang HC; Shin Y; Park HW; Park HR; Ku JL; Lim SB; Park JG
Hum Genet; 2003 Dec; 114(1):118-20. PubMed ID: 14513361
[TBL] [Abstract][Full Text] [Related]
4. [The roles of H. pylori infection and K-ras gene mutation in gastric carcinogenesis].
Hiyama T; Tanaka S; Haruma K; Chayama K
Nihon Rinsho; 2003 Jan; 61(1):46-9. PubMed ID: 12607314
[TBL] [Abstract][Full Text] [Related]
5. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
Wu M; Semba S; Oue N; Ikehara N; Yasui W; Yokozaki H
Gastric Cancer; 2004; 7(4):246-53. PubMed ID: 15616773
[TBL] [Abstract][Full Text] [Related]
6. [Relation of c-Ha-ras point mutation to the prognosis and metastasis of gastric carcinoma].
Deng GR
Zhonghua Yi Xue Za Zhi; 1989 Aug; 69(8):438-42, 32. PubMed ID: 2575929
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with K-ras mutation.
Xiong ZF; Shi J; Fu ZH; Wan HP; Tu LX
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28453172
[TBL] [Abstract][Full Text] [Related]
8. K-ras role in lung cancer therapy.
Zhang Z; Wang Z
Minerva Chir; 2011 Jun; 66(3):251-68. PubMed ID: 21666562
[TBL] [Abstract][Full Text] [Related]
9. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.
Linardou H; Dahabreh IJ; Kanaloupiti D; Siannis F; Bafaloukos D; Kosmidis P; Papadimitriou CA; Murray S
Lancet Oncol; 2008 Oct; 9(10):962-72. PubMed ID: 18804418
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutations in non-small-cell lung carcinoma: a review.
Aviel-Ronen S; Blackhall FH; Shepherd FA; Tsao MS
Clin Lung Cancer; 2006 Jul; 8(1):30-8. PubMed ID: 16870043
[TBL] [Abstract][Full Text] [Related]
11. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
12. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
[TBL] [Abstract][Full Text] [Related]
13. Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers.
Koh EH; Chung HC; Lee KB; Han EK; Oh SH; Min JS; Choi EM; Youn JK; Kim BS
J Korean Med Sci; 1992 Jun; 7(2):110-5. PubMed ID: 1524724
[TBL] [Abstract][Full Text] [Related]
14. [Detection of ras gene mutation in various stages of gastric cancer by PCR/RFLP SSCP and DNA sequencing].
Hao Y; Zhang J; Lu Y
Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):595-8. PubMed ID: 10436968
[TBL] [Abstract][Full Text] [Related]
15. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer.
Li M; Liu W; Zhu YF; Chen YL; Zhang BZ; Wang R
Acta Oncol; 2006; 45(8):1115-9. PubMed ID: 17118848
[TBL] [Abstract][Full Text] [Related]
16. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
17. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
18. [A simple look at the molecular biology of lung cancer: K-Ras].
Lena H; Corre R; Denis M
Rev Mal Respir; 2010 Jun; 27(6):639-43. PubMed ID: 20610078
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes.
Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E
Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
